Proportion of Patients Treated With Thrombolysis in a Centralized Versus a Decentralized Acute Stroke Care Setting | Zendy

Maarten M.H. Lahr | Zendy; GertJan Luijckx | Zendy; Patrick C. Vroomen | Zendy; Durk-Jouke van der Zee | Zendy; Erik Buskens | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proportion of Patients Treated With Thrombolysis in a Centralized Versus a Decentralized Acute Stroke Care Setting

Author(s) -

Maarten M.H. Lahr,

GertJan Luijckx,

Patrick C. Vroomen,

Durk-Jouke van der Zee,

Erik Buskens

Publication year - 2012

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.641795

Subject(s) - medicine , thrombolysis , confounding , tissue plasminogen activator , stroke (engine) , observational study , fibrinolytic agent , emergency medicine , logistic regression , mechanical engineering , myocardial infarction , engineering

Today, treatment of acute stroke consists of tissue-type plasminogen activator (tPA), admission to a stroke unit, and aspirin. Although tPA treatment is the most effective, there is substantial undertreatment. Centralized care may affect rate, timing, and outcome of thrombolysis compared to decentralized treatment in community hospitals. The present study aimed to assess the impact of organizational models on the proportion of patients undergoing tPA treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research